df Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • tenofovir  (Toronto Research Chemicals)
    93
    Toronto Research Chemicals tenofovir
    Median (IQR) <t>tenofovir</t> and tenofovir-dp in blood plasma and PBMCs following a single dose of tenofovir alafenamide. Tenofovir over 14 days in plasma (a) and tenofovir-dp in PBMCs (b). Plot inserts depict concentrations over 24 h for each matrix. Concentration values BLQ were imputed at half the LLOQ for graphing purposes. Broken horizontal lines represent the LLOQ. At least 32% of plasma samples had unquantifiable tenofovir and at least 8% of PBMC samples had unquantifiable tenofovir-dp. Percentage of samples that were BLQ at each sampling time is tabulated below each graph. TAF, tenofovir alafenamide.
    Tenofovir, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tenofovir/product/Toronto Research Chemicals
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tenofovir - by Bioz Stars, 2023-03
    93/100 stars
    		  Buy from Supplier
    human saliva pool  (Lee Biosolutions)
    91
    Lee Biosolutions human saliva pool
    Median (IQR) <t>tenofovir</t> and tenofovir-dp in blood plasma and PBMCs following a single dose of tenofovir alafenamide. Tenofovir over 14 days in plasma (a) and tenofovir-dp in PBMCs (b). Plot inserts depict concentrations over 24 h for each matrix. Concentration values BLQ were imputed at half the LLOQ for graphing purposes. Broken horizontal lines represent the LLOQ. At least 32% of plasma samples had unquantifiable tenofovir and at least 8% of PBMC samples had unquantifiable tenofovir-dp. Percentage of samples that were BLQ at each sampling time is tabulated below each graph. TAF, tenofovir alafenamide.
    Human Saliva Pool, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human saliva pool/product/Lee Biosolutions
    Average 91 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human saliva pool - by Bioz Stars, 2023-03
    91/100 stars
    		  Buy from Supplier
    jbj 1  (ATCC)
    96
    ATCC jbj 1
    Median (IQR) <t>tenofovir</t> and tenofovir-dp in blood plasma and PBMCs following a single dose of tenofovir alafenamide. Tenofovir over 14 days in plasma (a) and tenofovir-dp in PBMCs (b). Plot inserts depict concentrations over 24 h for each matrix. Concentration values BLQ were imputed at half the LLOQ for graphing purposes. Broken horizontal lines represent the LLOQ. At least 32% of plasma samples had unquantifiable tenofovir and at least 8% of PBMC samples had unquantifiable tenofovir-dp. Percentage of samples that were BLQ at each sampling time is tabulated below each graph. TAF, tenofovir alafenamide.
    Jbj 1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/jbj 1/product/ATCC
    Average 96 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    jbj 1 - by Bioz Stars, 2023-03
    96/100 stars
    		  Buy from Supplier
    protein extraction buffer df  (Covaris)
    92
    Covaris protein extraction buffer df
    Median (IQR) <t>tenofovir</t> and tenofovir-dp in blood plasma and PBMCs following a single dose of tenofovir alafenamide. Tenofovir over 14 days in plasma (a) and tenofovir-dp in PBMCs (b). Plot inserts depict concentrations over 24 h for each matrix. Concentration values BLQ were imputed at half the LLOQ for graphing purposes. Broken horizontal lines represent the LLOQ. At least 32% of plasma samples had unquantifiable tenofovir and at least 8% of PBMC samples had unquantifiable tenofovir-dp. Percentage of samples that were BLQ at each sampling time is tabulated below each graph. TAF, tenofovir alafenamide.
    Protein Extraction Buffer Df, supplied by Covaris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein extraction buffer df/product/Covaris
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    protein extraction buffer df - by Bioz Stars, 2023-03
    92/100 stars
    		  Buy from Supplier
    df camera  (Nikon)
    86
    Nikon df camera
    Median (IQR) <t>tenofovir</t> and tenofovir-dp in blood plasma and PBMCs following a single dose of tenofovir alafenamide. Tenofovir over 14 days in plasma (a) and tenofovir-dp in PBMCs (b). Plot inserts depict concentrations over 24 h for each matrix. Concentration values BLQ were imputed at half the LLOQ for graphing purposes. Broken horizontal lines represent the LLOQ. At least 32% of plasma samples had unquantifiable tenofovir and at least 8% of PBMC samples had unquantifiable tenofovir-dp. Percentage of samples that were BLQ at each sampling time is tabulated below each graph. TAF, tenofovir alafenamide.
    Df Camera, supplied by Nikon, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/df camera/product/Nikon
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    df camera - by Bioz Stars, 2023-03
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Median (IQR) tenofovir and tenofovir-dp in blood plasma and PBMCs following a single dose of tenofovir alafenamide. Tenofovir over 14 days in plasma (a) and tenofovir-dp in PBMCs (b). Plot inserts depict concentrations over 24 h for each matrix. Concentration values BLQ were imputed at half the LLOQ for graphing purposes. Broken horizontal lines represent the LLOQ. At least 32% of plasma samples had unquantifiable tenofovir and at least 8% of PBMC samples had unquantifiable tenofovir-dp. Percentage of samples that were BLQ at each sampling time is tabulated below each graph. TAF, tenofovir alafenamide.

    Journal: Journal of Antimicrobial Chemotherapy

    Article Title: Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

    doi: 10.1093/jac/dkx064

    Figure Lengend Snippet: Median (IQR) tenofovir and tenofovir-dp in blood plasma and PBMCs following a single dose of tenofovir alafenamide. Tenofovir over 14 days in plasma (a) and tenofovir-dp in PBMCs (b). Plot inserts depict concentrations over 24 h for each matrix. Concentration values BLQ were imputed at half the LLOQ for graphing purposes. Broken horizontal lines represent the LLOQ. At least 32% of plasma samples had unquantifiable tenofovir and at least 8% of PBMC samples had unquantifiable tenofovir-dp. Percentage of samples that were BLQ at each sampling time is tabulated below each graph. TAF, tenofovir alafenamide.

    Article Snippet: 1 mg/mL drug stocks were prepared by diluting tenofovir alafenamide (MedChem Express, Monmouth Junction, NJ, USA) in 100% DMSO and tenofovir (Toronto Research Chemicals, Toronto, ON, Canada) in purified water.

    Techniques: Concentration Assay, Sampling

    Tenofovir and tenofovir-dp NCA

    Journal: Journal of Antimicrobial Chemotherapy

    Article Title: Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

    doi: 10.1093/jac/dkx064

    Figure Lengend Snippet: Tenofovir and tenofovir-dp NCA

    Article Snippet: 1 mg/mL drug stocks were prepared by diluting tenofovir alafenamide (MedChem Express, Monmouth Junction, NJ, USA) in 100% DMSO and tenofovir (Toronto Research Chemicals, Toronto, ON, Canada) in purified water.

    Techniques:

    Median (IQR) tenofovir and tenofovir-dp in rectal tissues following a single dose of tenofovir alafenamide. Tenofovir (continuous lines) and tenofovir-dp (broken lines) over 14 days in rectal tissue. Concentration values BLQ were imputed at half the sample-specific LLOQ for graphing purposes. Representative LLOQs are depicted for tenofovir (continuous horizontal line) and tenofovir-dp (broken horizontal line). At least 25% and 69% of samples had unquantifiable tenofovir and tenofovir-dp, respectively. Percentage of samples that were BLQ at each sampling time is tabulated below the graph. TAF, tenofovir alafenamide; TFV, tenofovir; TFVdp, tenofovir-dp.

    Journal: Journal of Antimicrobial Chemotherapy

    Article Title: Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

    doi: 10.1093/jac/dkx064

    Figure Lengend Snippet: Median (IQR) tenofovir and tenofovir-dp in rectal tissues following a single dose of tenofovir alafenamide. Tenofovir (continuous lines) and tenofovir-dp (broken lines) over 14 days in rectal tissue. Concentration values BLQ were imputed at half the sample-specific LLOQ for graphing purposes. Representative LLOQs are depicted for tenofovir (continuous horizontal line) and tenofovir-dp (broken horizontal line). At least 25% and 69% of samples had unquantifiable tenofovir and tenofovir-dp, respectively. Percentage of samples that were BLQ at each sampling time is tabulated below the graph. TAF, tenofovir alafenamide; TFV, tenofovir; TFVdp, tenofovir-dp.

    Article Snippet: 1 mg/mL drug stocks were prepared by diluting tenofovir alafenamide (MedChem Express, Monmouth Junction, NJ, USA) in 100% DMSO and tenofovir (Toronto Research Chemicals, Toronto, ON, Canada) in purified water.

    Techniques: Concentration Assay, Sampling

    Median (IQR) tenofovir and tenofovir-dp in female genital tissues following a single dose of tenofovir alafenamide. Tenofovir (continuous lines) and tenofovir-dp (broken lines) over 14 days in FGT tissue. Concentration values BLQ were imputed at half the sample-specific LLOQ for graphing purposes. Representative LLOQs are depicted for tenofovir (continuous horizontal line) and tenofovir-dp (broken horizontal line). At least 31% and 87.5% of samples had unquantifiable tenofovir and tenofovir-dp, respectively. Percentage of samples that were BLQ at each sampling time is tabulated below the graph. TAF, tenofovir alafenamide; TFV, tenofovir; TFVdp, tenofovir-dp.

    Journal: Journal of Antimicrobial Chemotherapy

    Article Title: Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

    doi: 10.1093/jac/dkx064

    Figure Lengend Snippet: Median (IQR) tenofovir and tenofovir-dp in female genital tissues following a single dose of tenofovir alafenamide. Tenofovir (continuous lines) and tenofovir-dp (broken lines) over 14 days in FGT tissue. Concentration values BLQ were imputed at half the sample-specific LLOQ for graphing purposes. Representative LLOQs are depicted for tenofovir (continuous horizontal line) and tenofovir-dp (broken horizontal line). At least 31% and 87.5% of samples had unquantifiable tenofovir and tenofovir-dp, respectively. Percentage of samples that were BLQ at each sampling time is tabulated below the graph. TAF, tenofovir alafenamide; TFV, tenofovir; TFVdp, tenofovir-dp.

    Article Snippet: 1 mg/mL drug stocks were prepared by diluting tenofovir alafenamide (MedChem Express, Monmouth Junction, NJ, USA) in 100% DMSO and tenofovir (Toronto Research Chemicals, Toronto, ON, Canada) in purified water.

    Techniques: Concentration Assay, Sampling

    In vitro tenofovir-dp formation in PBMCs and epithelial cells

    Journal: Journal of Antimicrobial Chemotherapy

    Article Title: Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

    doi: 10.1093/jac/dkx064

    Figure Lengend Snippet: In vitro tenofovir-dp formation in PBMCs and epithelial cells

    Article Snippet: 1 mg/mL drug stocks were prepared by diluting tenofovir alafenamide (MedChem Express, Monmouth Junction, NJ, USA) in 100% DMSO and tenofovir (Toronto Research Chemicals, Toronto, ON, Canada) in purified water.

    Techniques: In Vitro

    Median (range) tenofovir-dp in PBMCs and epithelial cells incubated in tenofovir and tenofovir alafenamide. Tenofovir-dp concentration over time in human PBMCs (triangles), Ect1/E6E7 ectocervical epithelial cells (circles) and VK2/E6E7 vaginal epithelial cells (squares) incubated in 0.5 μM (a) or 10 μM (b) tenofovir alafenamide (filled symbols and continuous lines) or tenofovir (open symbols and broken lines). Tenofovir-dp accumulation plateaued by 24 h in vaginal epithelial cells and 48 h in cervical epithelial cells and PBMCs for both tenofovir alafenamide and tenofovir.

    Journal: Journal of Antimicrobial Chemotherapy

    Article Title: Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

    doi: 10.1093/jac/dkx064

    Figure Lengend Snippet: Median (range) tenofovir-dp in PBMCs and epithelial cells incubated in tenofovir and tenofovir alafenamide. Tenofovir-dp concentration over time in human PBMCs (triangles), Ect1/E6E7 ectocervical epithelial cells (circles) and VK2/E6E7 vaginal epithelial cells (squares) incubated in 0.5 μM (a) or 10 μM (b) tenofovir alafenamide (filled symbols and continuous lines) or tenofovir (open symbols and broken lines). Tenofovir-dp accumulation plateaued by 24 h in vaginal epithelial cells and 48 h in cervical epithelial cells and PBMCs for both tenofovir alafenamide and tenofovir.

    Article Snippet: 1 mg/mL drug stocks were prepared by diluting tenofovir alafenamide (MedChem Express, Monmouth Junction, NJ, USA) in 100% DMSO and tenofovir (Toronto Research Chemicals, Toronto, ON, Canada) in purified water.

    Techniques: Incubation, Concentration Assay